Parathyroid scintigraphy with iodine-123 and 99mTc-sestamibi: imaging findings

Area of Science:

• Nuclear Medicine
• Radiology
• Endocrinology

Background:

• Traditional subtraction scintigraphy using 99mTc-pertechnetate and 201Tl-chloride has limited sensitivity (avg. 55%) for parathyroid gland localization.
• Improved scintigraphic techniques are crucial for accurate diagnosis of parathyroid disorders.

Purpose of the Study:

• To illustrate the effectiveness of combining 99mTc-sestamibi and iodine-123 for visualizing parathyroid gland abnormalities.
• To highlight the advantages of this dual-tracer approach over conventional methods.

Main Methods:

• Utilizing a combination of 99mTc-sestamibi and iodine-123 for parathyroid scintigraphy.
• Employing sequential imaging with 99mTc-sestamibi, subtracting early from late images to visualize parathyroid adenomas.
• Leveraging the rapid washout of 99mTc-sestamibi from the thyroid gland for enhanced parathyroid visualization.

Main Results:

• The combination of 99mTc-sestamibi and iodine-123 significantly improves scintigraphic sensitivity for parathyroid localization.
• 99mTc-sestamibi alone, through sequential image subtraction, effectively localizes parathyroid adenomas.
• Fast technetium-99m-sestamibi washout from the thyroid facilitates clear visualization of the parathyroid glands.

Conclusions:

• Dual-tracer scintigraphy with 99mTc-sestamibi and iodine-123 offers enhanced sensitivity for detecting parathyroid abnormalities.
• This advanced imaging technique provides a more accurate method for localizing parathyroid adenomas.
• The findings support the use of this combined approach in the diagnostic workup of parathyroid conditions.